Servier
Highly Engaged Employees
Manufacturing · France · 10K+ Employees
View Company Info for Free
Overview
Headquarters
50 Rue Carnot, Suresnes, Ile-de-France, ...Phone Number
+33 155727010Website
www.servier.comRevenue
$6 BillionIndustry
About Servier
Servier Org Chart
Is Servier your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Servier
Check if Servier has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Servier has new funding data
Check out if Servier is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Servier launches new products
Earning: See what the market has to say on Servier recently announced quarterly report
Servier, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Servier had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Servier is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Servier is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Servier.
Servier Tech Stack
A closer look at the technologies used by Servier
Most Recent Scoops
Servier News & Media
Promising Phase 1 Data for Servier's Emiltatug Ledadotin (Emi-Le) in Adenoid Cystic Carcinoma (ACC) Presented at ASCO 2026
Emi-Le recently received Breakthrough Designation from the U.S. Food and Drug Administration (FDA) for the proposed treatment of patients with locally advanced, recurrent or metastatic ACC with solid histology or high-grade transformation Oral presentation shows Emi-Le was well tolerated...Servier buys into muscular dystrophy with potentially $2.7B deal
The French drugmaker has agreed to acquire an experimental tablet from Edgewise Therapeutics that some bullish analysts say could eventually hit peak sales of over $2 billion.Servier to Present Extended Follow-Up Results from the Phase 3 INDIGO Trial Showing Durable and Sustained Treatment Benefits of VORANIGO® (vorasidenib) at ASCO 2026
Latest long-term analysis, including more than three years of follow-up data of patients with Grade 2 IDH-mutant glioma treated with VORANIGO® (vorasidenib), will be presented in a rapid oral session on May 31 at 4:36 p.m. CDT Results show median progression-free survival among patients...Servier Presentations at ASCO 2026 Spotlight Expanding Rare Oncology Portfolio
Updated efficacy and safety data from a long-term analysis of the Phase 3 INDIGO trial of VORANIGO® (vorasidenib) will be presented in a rapid oral presentation Results from an ongoing Phase 1 trial evaluating investigational compound Emi-Le in adenoid cystic carcinoma will be shared in...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Servier
Founded in 1954 and headquartered in Suresnes, France, Servier international is an independent pharmaceutical company governed by a non-profit foundation. Their three research centres are continuously involved in creating, testing, and developing new medicinal products, which are manufactured and packaged in their production centres around the worl... Read More